ApoB and Lp(a): core measures to assess cardiovascular risk.
Publication
, Journal Article
Sniderman, AD; Pencina, MJ; Thanassoulis, G
Published in: Eur Heart J
July 14, 2025
Duke Scholars
Published In
Eur Heart J
DOI
EISSN
1522-9645
Publication Date
July 14, 2025
Volume
46
Issue
27
Start / End Page
2702 / 2704
Location
England
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Sniderman, A. D., Pencina, M. J., & Thanassoulis, G. (2025). ApoB and Lp(a): core measures to assess cardiovascular risk. Eur Heart J, 46(27), 2702–2704. https://doi.org/10.1093/eurheartj/ehaf204
Sniderman, Allan D., Michael J. Pencina, and George Thanassoulis. “ApoB and Lp(a): core measures to assess cardiovascular risk.” Eur Heart J 46, no. 27 (July 14, 2025): 2702–4. https://doi.org/10.1093/eurheartj/ehaf204.
Sniderman AD, Pencina MJ, Thanassoulis G. ApoB and Lp(a): core measures to assess cardiovascular risk. Eur Heart J. 2025 Jul 14;46(27):2702–4.
Sniderman, Allan D., et al. “ApoB and Lp(a): core measures to assess cardiovascular risk.” Eur Heart J, vol. 46, no. 27, July 2025, pp. 2702–04. Pubmed, doi:10.1093/eurheartj/ehaf204.
Sniderman AD, Pencina MJ, Thanassoulis G. ApoB and Lp(a): core measures to assess cardiovascular risk. Eur Heart J. 2025 Jul 14;46(27):2702–2704.
Published In
Eur Heart J
DOI
EISSN
1522-9645
Publication Date
July 14, 2025
Volume
46
Issue
27
Start / End Page
2702 / 2704
Location
England
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology